The Comprehensive Assessment of Neurodegeneration and Dementia Study

Overview

Acronym
COMPASS-ND
Website
COMPASS-ND
Investigators
Dr. Michael Borrie
University of Western Ontario
Dr. Louis Verret
Hôpital de l'Enfant-Jésus
Dr. Serge Gauthier
McGill University
Dr. Stéphanie Yamin
Saint Paul University
Dr. Mario Masellis
Sunnybrook Research Institute
Dr. Richard Camicioli
University of Alberta
Dr. Ging-Yuek Robin Hsiung
University of British Columbia
Dr. Jacqui Pettersen
University of Northern British Columbia
Contacts
Dr. Victor Whitehead
Jewish General Hospital

General Design

Study design
Cohort
Start - End Year
2016 -
General Information on Follow Up (profile, frequency)
Recruitment Target
  • Individuals
Number of Participants
1,650
Number of Participants with Biological Samples
1,650
Supplementary information about number of participants

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Marker Paper

Das S., Mohades Z., Strauss T., Campbell T., Borrie M., Fogarty J., Whitehead V., Pillon R.,Lindsay J., Best S.Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND) Study: Implementing the Clinical Cohorts Platform. Canadian Geriatrics Journal. 2016 Sep; 19(3): 154–155.

PUBMED 31309917

Timeline

Population

COMPASS-ND population

Selection Criteria

Minimum age
50
Maximum age
90
Countries
  • Canada
Canadian Provinces
  • Alberta
  • British Columbia
  • Newfoundland and Labrador
  • Ontario
  • Prince Edward Island
  • Quebec
  • Saskatchewan
Territory
St. John, Quebec City, Montreal, Ottawa, Toronto, Kitchener/Waterloo, London, Saskatoon, Edmonton, Calgary, Vancouver and Prince George.
Health Status

Sources of Recruitment

Specific Population
  • Clinic patients
Supplementary Information

Sample Size

Number of Participants
1,650
Number of Participants with Biological Samples
1,650
Supplementary information about number of participants

Data Collection Events

# Name Data sources Data sources - Biosamples Start End
0 COMPASS-ND - Baseline
  • Questionnaires
  • Cognitive measures
  • Physical measures
  • Biosamples
  • Blood
  • Urine
  • Saliva
  • Buccal cells
  • Other : Cerebrospinal fluid, fecal sample, brain
2016 (April) 2018 (March)
1 COMPASS-ND - 2 years follow-up
  • Questionnaires
  • Cognitive measures
  • Physical measures
  • Biosamples
  • Blood
  • Urine
  • Saliva
  • Buccal cells
  • Other : Cerebrospinal fluid, fecal sample, brain
2018 (April) 2020 (March)

Participating Studies

Acronym Name Study design Countries

Harmonization Initiatives Included

Acronym Name

Datasets

Name Data Collection Events Variables

Areas of Information Collected

Socio-demographic and economic characteristics
Death
Lifestyle and behaviours
Physical measures and assessments
Birth, pregnancy and reproductive health history
Laboratory measures
Perception of health, quality of life, development and functional limitations
Cognition, personality and psychological measures and assessments
Diseases
Life events, life plans, beliefs and values
Symptoms and signs
Preschool, school and work life
Medication and supplements
Social environment and relationships
Non-pharmacological interventions
Physical environment
Health and community care services utilization
Administrative information

Variables Content Summary

Areas of Information Collected
No Areas of Information Collected
No Scales Collected
Areas of Information Collected per per Population and Data Collection Event
No Areas of Information Collected
No Scales Collected

Networks

Acronym Name Harmonization Initiatives Individual Studies
Last Update: 2023-08-10T18:18:41.393